Tablet splitting: A review of weight and content uniformity: Part 1 of a 2-part series. Next month: Table splitting - A review of the clinical and economic

Consultant Pharmacist

Volumn 27, Issue 5, 2012, Pages 341-352

  Freeman, Maisha Kelly ^a   White, Whitney ^a   Iranikhah, Maryam ^a  

^a SAMFORD UNIVERSITY   (United States)

Author keywords

Content uniformity; Tablet splitting; Weight uniformity

Indexed keywords

AMLODIPINE; AMLODIPINE BESYLATE; ATENOLOL; ATORVASTATIN; CITALOPRAM; DIGOXIN; DILTIAZEM; ENACARD; ENALAPRIL; FUROSEMIDE; GABAPENTIN; GLIBENCLAMIDE; GLIPIZIDE; HYDROCHLOROTHIAZIDE; LISINOPRIL; METFORMIN; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; MEVINOLIN; PAROXETINE; PIMOBENDAN; PROPRANOLOL; RISPERIDONE; ROFECOXIB; SERTRALINE; SILDENAFIL; SIMVASTATIN; SOTALOL; SPIRONOLACTONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VETMEDIN; WARFARIN;

BIBLIOGRAPHIC DATABASE; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL STUDY; CONFIDENCE INTERVAL; DATA EXTRACTION; DRUG COST; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG STABILITY; DRUG USE; ETHICS; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; LEGAL ASPECT; MEDICAL ETHICS; MEDICAL PRACTICE; MEDICAL SOCIETY; MEDLINE; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; STUDENT T TEST; TABLET PROPERTY; TABLET SPLITTING;

DRUG COSTS; DRUG STABILITY; DRUG THERAPY; GUIDELINES AS TOPIC; HUMANS; LEGISLATION, DRUG; PATIENT EDUCATION AS TOPIC; PHARMACEUTICAL PREPARATIONS; TABLETS; UNITED STATES;

EID: 84861651146     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2012.341     Document Type: Review

References (33)

1. Poll JE, Kim S, Martin BR. Weight uniformity of split tablets required by a Veterans Affairs policy. J Managed Care Pharm 2003;9:401-7.
2. Weissman EM, Dellenbaugh C. Impact of splitting risperidone tablets on medication adherence and on clinical outcomes for patient with schizophrenia. Psychiatr Serv 2007;58:201-6. (Pubitemid 46340463)
3. Gee M, Hasson NK, Hahn T et al. Effects of a tablet-splitting program in patients taking HMG-CoA reductase inhibitors: analysis of clinical effects, patient satisfaction, compliance, and cost avoidance. J Manag Care Pharm 2002;8:453-8.
4. Vuchetich PJ, Garis RI, Jorgensen AMD. Evaluation of cost savings to a state Medicaid program following sertraline tablet-splitting program. J Am Pharm Assoc. 2003;43:497-502.
5. Dobscha SK, Anderson TA, Hoffman WF et al. Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center. Psychiatr Serv 2003;54:195-200. (Pubitemid 36752850)
6. Verrue C, Mehuys E, Boussery K et al. Tablet-splitting: a common yet not so innocent practice. J Adv Nursing 2010;67:26-32.
7. Tablet splitting. Med Lett Drugs Ther 2009;51:62-3.
8. Margiocco ML, Warren J, Borgarelli M et al. Analysis of weight uniformity, content uniformity and 20-day stability in halves and quarters of routinely prescribed cardiovascular medications. J Vet Cardiol 2009;11:31-9.
9. Dormuth CR, Schneeweiss S, Brookhart AM et al. Frequency and predictors of tablet splitting in statin prescriptions: a population-based analysis. Open Med 2008;2:74-82.
10. Peek BT, Al-Achi A, Coombs SJ. Accuracy of tablet splitting by elderly patients. JAMA 2002;288:451-2. (Pubitemid 34787475)
11. Hill SW, Varker AS, Karlage K et al. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications. J Manag Care Pharm 2009;15:253-61.
12. Wolfgang SA. Olanzapine in whole, not half, tablets for psychosis from Alzheimer's dementia. Am J Health Syst Pharm 1999;56:2245-6. (Pubitemid 29531734)
13. Revisiting tablet splitting. Drug Management Forum http:// www.drugmanagementforum.com/forum/managed-care-pharmacy- administrative-issues/ 8774-revisiting-tablet-splitting. html. Accessed July 23, 2011.
14. San Francisco Chronicle examines use of pill-splitting programs by health insurers. Kaiser Health News http://www. aamedya.com/health/linkac.php?id=http: //www.kaisernetwork. org. Accessed March 26, 2011.
15. VISN Tablet Splitting Medications. www1.pacific.edu/~npettit/ Tablet-Split-List.doc. Accessed June 10, 2011.
16. VHA Formulary Management Process. http://www.pbm. va.gov/directive/ vhadirective.pdf. Accessed June 10, 2011.
17. Newly approved professional pharmacy services save time, money. http://media.alabama.gov/pr/pr.aspx?id=5314&t=1. Accessed July 10, 2011.
18. APhA Resource: Practice. Tablet splitting: evaluating appropriateness for patients. J Am Pharm Assoc 2004;44:324-5.
19. Tablet splitting: a risky practice. FDA Consumer update http:// www.fda.gov/ForConsumers/ConsumerUpdates/ucm171492.htm. Accessed March 28, 2011.
20. U.S. Pharmacopeia. United States Pharmacopeia and National Formulary (USP 33-NF 28 Reissue) [CD-ROM]. Rockville, MD: US Pharmacopeia; 2010:chap 905.
21. Zhao N, Zidan A, Tawakkul M et al. Tablet splitting: product quality assessment of metoprolol succinate extended release tablets. Int J Pharm 2010;401:25-31.
22. Volpe DA, Gupta A, Ciavarella AB et al. Comparison of stability of split and intact gabapentin tablets. Int J Pharm 2008;350:65-9.
23. Nolly RJ, Rodrigues P, Thoma L. Weight variability of scored and unscored psychotropic drug tablets split by a uniquely designed tablet splitting device. Hosp Pharm 2005;40:321-5. (Pubitemid 40571362)
24. Rashed SM, Nolly RJ, Robinson L et al. Weight variability of scored and unscored split psychotropic drug tablets. Hosp Pharm 2003;38:930-4. (Pubitemid 37267652)
25. Teng J, Song CK, Williams RL et al. Lack of medication dose uniformity in commonly split tablets. J Am Pharm Assoc 2002;42:195-9.
26. Rosenberg JM, Nathan JP, Plakogiannis F. Weight variability of pharmacist-dispensed split tablets. J Am Pharm Assoc. 2002;42:200-5.
27. Cook TH, Edwards S, Gyemah C et al. Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10 mg tablets. J Am Pharm Assoc 2004;44:583-6.
28. Boggie DT, DeLattre ML, Schaefer MG et al. Accuracy of splitting unscored valdecoxib tablets. Am J Health Syst Pharm 2004;61:1482-3. (Pubitemid 39481421)
29. McDevitt JT, Gurst AH, Chen Y. Accuracy of tablet splitting. Pharmacother 1998;18:193-7. (Pubitemid 28059015)
30. Cohen CI, Cohen SI. Potential savings from splitting newer antidepressant medications. CNS Drugs 2002;16:353-8. (Pubitemid 34548202)
31. Hamer AM, Hartung DM, Haxby DG et al. Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid program. J Manag Care Pharm 2006;12:449-56. (Pubitemid 47400585)
32. Rindone JP. Evaluation of tablet-splitting in patients taking lisinopril for hypertension. JCOM 2000;7:22-4.
33. Bult J, Schiff G, Wisniewski M. Sertraline tablet splitting program. Hosp Pharm 1999;34:996-9. (Pubitemid 30151970)